NCT04566848View on ClinicalTrials.gov

The Status of Immune Checkpoints at Gastrointestinal Cancer

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

January 1, 2022

Study Completion Date

January 1, 2022

Conditions
Gastrointestinal Cancer
Interventions
DIAGNOSTIC_TEST

Flow cytometric analysis

Measuring the sCD25 (IL-2Ra), 4-1BB, B7.2 (CD86), Free Active TGF-β1, CTLA-4, PD-L1, PD-1, Tim-3, LAG-3, Galectin-9 levels with flow cytometry

Trial Locations (1)

34098

Istanbul Training and Reseach Hospital, Istanbul

All Listed Sponsors
collaborator

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

OTHER

lead

Istanbul Training and Research Hospital

OTHER_GOV

NCT04566848 - The Status of Immune Checkpoints at Gastrointestinal Cancer | Biotech Hunter | Biotech Hunter